Syndax Pharmaceuticals Inc at Stifel Virtual Healthcare Conference Transcript
Good afternoon, and thank you all for joining us. This is Konstantinos Aprilakis. I recently joined the health care equity research team here at Stifel, as a senior biotech analyst. It's my pleasure to introduce Dr. Briggs Morrison, CEO of Syndax. The Syndax team have kindly prepared a brief corporate presentation for us.
Please note that this session will not feature a live Q&A. We ask that you submit any questions for the company directly to our corporate access team via e-mail that can be reached at [email protected]. That's all one word, [email protected]. And with that, I'll turn it over to you, Briggs.
Thanks so much, Konstantin. Pleasure to be here today to tell you -- bring you up-to-date on where we are in our corporate journey. Let me start with our forward look statement. Again, you can reference our SEC documents to see all the various
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |